Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Kouichi, Takaguchi"'
Autor:
Jun Itakura, Masayuki Kurosaki, Chitomi Hasebe, Yukio Osaki, Kouji Joko, Hitoshi Yagisawa, Shinya Sakita, Hiroaki Okushin, Takashi Satou, Hiroyuki Hisai, Takehiko Abe, Keiji Tsuji, Takashi Tamada, Haruhiko Kobashi, Akeri Mitsuda, Yasushi Ide, Chikara Ogawa, Syotaro Tsuruta, Kouichi Takaguchi, Miyako Murakawa, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0165339 (2016)
We aimed to clarify the characteristics of resistance-associated substitutions (RASs) after treatment failure with NS5A inhibitor, daclatasvir (DCV) in combination with NS3/4A inhibitor, asunaprevir (ASV), in patients with chronic hepatitis C virus g
Externí odkaz:
https://doaj.org/article/b9240e38227148be9226cb4333c32437
Autor:
Akemi Tsutsui, Yasuni Nakanuma, Kouichi Takaguchi, Satoko Nakamura, Hiroshi Shibata, Nobuyuki Baba, Tomonori Senoh, Takuya Nagano, Hiroko Ikeda
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
The liver biopsy remains a valuable tool in the diagnosis of drug-induced liver injury (DILI). The Digestive Disease Week Japan 2004 (DDW-J) scale proposed as an objective tool for the diagnosis of DILI has been widely used in Japan. So far, the hist
Externí odkaz:
https://doaj.org/article/8f07b891416e4786968afb9bd487d59b
Publikováno v:
香川県立保健医療大学雑誌 = Journal of Kagawa Prefectural University of Health Sciences. 10:35-43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::55d5cce618948b643e2e588bdbca6eaa
http://id.nii.ac.jp/1751/00000219/
http://id.nii.ac.jp/1751/00000219/
Autor:
Hirohito Yoneyama, Yasunori Minami, Joji Tani, Atsushi Kubo, Kazuomi Ueshima, Chikara Ogawa, Akio Moriya, Masaharu Ando, Akihiro Deguchi, Kouichi Takaguchi, Naoshi Nishida, Toshihiro Matsunaka, Mitsushige Shibatoge, Asahiro Morishita, Akemi Tsutsui, Toshiharu Sakurai, Hiroyuki Tamaki, Akina Omura, Teruyo Noda, Tsutomu Masaki, Masahiro Morita, Yasutaka Kokudo, Masatoshi Kudo, Takuya Nagano, Tomonori Senoh
Publikováno v:
Oncology. 93:113-119
Objective: To determine the relationship between treatment outcomes and hand-foot syndrome (HFS), and the relationship between survival rate and post-progression treatment after sorafenib therapy. Methods: The study assessed 314 patients with advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c98319d082a5567629345769165fc0
https://doi.org/10.1159/000481241
https://doi.org/10.1159/000481241
Autor:
Joji Tani, Akio Moriya, Tomoko Tadokoro, Chikara Ogawa, Mai Nakahara, Hirohito Yoneyama, Kei Takuma, Akihiro Deguchi, Asahiro Morishita, Tsutomu Masaki, Takuya Nagano, Hideki Kobara, Kouichi Takaguchi, Takako Nomura, Shima Mimura, Tomonori Senoh, Teppei Sakamoto, Akemi Tsutsui, Koji Fujita, Kyoko Oura, Takashi Himoto
Publikováno v:
Oncology Letters
Direct acting antivirals (DAA) have recently been developed to treat patients with hepatitis C virus (HCV) infection, and interferon-free DAA treatment has improved the cure rate of patients. However, the occurrence rate of hepatocellular carcinoma (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148324ca401dfd79831b148dcb1c60c5
https://pubmed.ncbi.nlm.nih.gov/32194718
https://pubmed.ncbi.nlm.nih.gov/32194718
Autor:
Shintarou, Nanba, Fusao, Ikeda, Shin-Ichi, Fujioka, Yasuyuki, Araki, Kouichi, Takaguchi, Noriaki, Hashimoto, Hiroyuki, Seki, Akinobu, Takaki, Yoshiaki, Iwasaki, Kazuhide, Yamamoto
Publikováno v:
Acta Medica Okayama. 69(4):237-244
The effectiveness of extending treatment duration as response guided therapy was previously reported for chronic hepatitis C (CHC) genotype 1, but is still controversial for genotype 2. The present study is a retrospective cohort study to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2f86db21cbc79ffbef4a66924a86af36
https://ousar.lib.okayama-u.ac.jp/53560
https://ousar.lib.okayama-u.ac.jp/53560
Autor:
Takashi Satou, Kouichi Takaguchi, Nobuyuki Enomoto, Yasuhiro Asahina, Namiki Izumi, Haruhiko Kobashi, Takehiko Abe, Yasushi Ide, Shinya Sakita, Syotaro Tsuruta, Kouji Joko, Keiji Tsuji, Hiroyuki Hisai, Yukio Osaki, Hiroaki Okushin, Jun Itakura, Chikara Ogawa, Miyako Murakawa, Chitomi Hasebe, Hitoshi Yagisawa, Tamada T, Masayuki Kurosaki, Akeri Mitsuda
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0165339 (2016)
PLoS ONE
PLoS ONE
Backgrounds & Aims We aimed to clarify the characteristics of resistance-associated substitutions (RASs) after treatment failure with NS5A inhibitor, daclatasvir (DCV) in combination with NS3/4A inhibitor, asunaprevir (ASV), in patients with chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dffcc0634fdf5d008b5b96b33569afbb
http://europepmc.org/articles/PMC5077083?pdf=render
http://europepmc.org/articles/PMC5077083?pdf=render
Autor:
Kazuaki Chayama, Mie Inao, Tsutomu Kawai, Yoichi Hiasa, Yasuhiro Asahina, Eiji Tanaka, Gotaro Yamada, Makoto Oketani, Hiroshi Yatsuhashi, Namiki Izumi, Osamu Yokosuka, Shinji Katsushima, Yukishige Okamura, Hisataka Moriwaki, Masatoshi Kudo, Takayuki Takeuchi, Hiromitsu Kumada, Kouichi Takaguchi, Hiroshi Adachi, Eiji Kajiwara, Kazuya Kariyama, Joji Toyoda, Masayuki Kurosaki
Publikováno v:
Journal of Gastroenterology
Background We investigated whether the administration of maintenance doses of interferon prevented hepatocellular carcinoma (HCC) in patients with chronic hepatitis C. Methods Study 1: A multicenter, retrospective, cooperative study was carried out t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c2badf251c5d6889b8c1b37181a9f17
http://europepmc.org/articles/PMC3618412
http://europepmc.org/articles/PMC3618412
Autor:
Joji Tani, Akemi Tsutsui, Hirohito Yoneyama, Tsutomu Masaki, Masatoshi Kudo, Mitsushige Shibatoge, Masaharu Ando, Takuya Nagano, Akihiro Deguchi, Chikara Ogawa, Masahiro Morita, Kouichi Takaguchi, Asahiro Morishita, Tomonori Senoh, Akina Omura, Akio Moriya
Publikováno v:
Annals of Oncology. 29:vii52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb815cbe373a358533eec8eb9828efab
https://doi.org/10.1093/annonc/mdy374.005
https://doi.org/10.1093/annonc/mdy374.005
Autor:
Kohsaku Sakaguchi, Yasuhiro Makino, Haruhiko Kobashi, Yoshiaki Iwasaki, Akinobu Takaki, Ryoichi Okamoto, Masaharu Ando, Fusao Ikeda, Kazuhide Yamamoto, Hiroshi Ikeda, Tetsuya Yasunaka, Yasuhiro Miyake, Kouichi Takaguchi
Publikováno v:
Hepatology International. 3:556-562
This study aimed to investigate the efficacy of ursodeoxycholic acid (UDCA) for Japanese patients with autoimmune hepatitis (AIH).One hundred forty-seven patients were investigated.As initial treatment, 25 patients received UDCA (300-600 mg/day) mono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdf3d5a6ede9216696aadb918fffb86b
https://doi.org/10.1007/s12072-009-9155-9
https://doi.org/10.1007/s12072-009-9155-9